0000914190-17-000026.txt : 20170203
0000914190-17-000026.hdr.sgml : 20170203
20170203185403
ACCESSION NUMBER: 0000914190-17-000026
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170201
FILED AS OF DATE: 20170203
DATE AS OF CHANGE: 20170203
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIO-TECHNE Corp
CENTRAL INDEX KEY: 0000842023
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 411427402
STATE OF INCORPORATION: MN
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 614 MCKINLEY PL N E
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
BUSINESS PHONE: 6123798854
MAIL ADDRESS:
STREET 1: 614 MCKINLEY PLACE NE
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNE CORP /MN/
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gavin Robert M.
CENTRAL INDEX KEY: 0001608023
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-17272
FILM NUMBER: 17573622
MAIL ADDRESS:
STREET 1: C/O PROTEINSIMPLE
STREET 2: 3040 OAKMEAD VILLAGE DRIVE
CITY: SANTA CLARA
STATE: CA
ZIP: 95051
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2017-02-01
0000842023
BIO-TECHNE Corp
TECH
0001608023
Gavin Robert M.
614 MCKINLEY PLACE NE
MINNEAPOLIS
MN
55413
0
1
0
0
Senior V.P. Protein Platforms
Common Stock
2017-02-01
4
M
0
1667
0
A
1667
D
Stock Option (Right to Buy)
93.32
2021-07-31
Common Stock
10000
10000
D
Stock Option (Right to Buy)
93.32
2017-02-01
4
D
0
33333
0
D
2021-07-31
Common Stock
33333
16667
D
Stock Option (Right to Buy)
90.25
2021-11-30
Common Stock
5000
5000
D
Restricted Stock Units
2017-02-01
4
M
0
1667
0
D
Common Stock
1667
0
D
Stock Option (Right to Buy)
108.49
2022-08-07
Common Stock
12500
12500
D
Stock Option (Right to Buy)
108.49
2022-08-07
Common Stock
9375
9375
D
Restricted Stock Units
Common Stock
1500
1500
D
Stock Option (Right to Buy)
106.59
2016-08-18
4
A
0
17371
0
A
2023-08-18
Common Stock
17371
17371
D
Stock Option (Right to Buy)
106.59
2016-08-18
4
A
0
13028
0
A
2023-08-18
Common Stock
13028
13028
D
Restricted Stock Units
2016-08-18
4
A
0
2111
0
A
Common Stock
2111
2111
D
2,500 shares vest on each of 7/31/15, 7/31/16, 7/31/17 and 7/31/18.
On 2/1/17, the Board of Directors authorized discretionary vesting for 16,667 performance options. The remainder of the performance options were forfeited.
1,500 shares vest on each of 12/1/15, 12/1/16, 12/1/17 and 12/1/18.
On 2/1/17, the Board of Directors authorized discretionary vesting for 1,667 performance RSUs. The remainder of the performance RSUs were foreited.
3,125 shares vest on each of 8/7/16, 8/7/17, 8/7/18 and 8/7/19.
Each restricted stock unit represents a contingent right to receive one shares of Bio-Techne common stock.
Vests in full or in part on 8/7/18 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Vests 4,343 shares on each of 8/18/17, 8/18/18 and 8/18/19, and 4,342 shares on 8/18/20.
Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
/s/ Elizabeth M. Dunshee as Attorney-in-Fact for Robert M. Gavin pursuant to Power of Attorney previously filed.
2017-02-03